Cell Line Development Market with COVID-19 Impact Analysis, By Product (Reagent and Media, Equipment, Accessories and consumables, Services), By Type of Cell Lines (Recombinant cell lines, Hybridomas, Continuous cell lines, Primary cell lines), By Application (Bioproduction, Drug discovery, Toxicity testing, Tissue engineering, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Cell Line Development Market size was valued at USD 4,810 Million in 2022, expanding at a CAGR of 9.81 % from 2023 to 2030.
Cell line development is a vital process in the biotechnology and pharmaceutical industries that involves the generation and selection of specialized cells that can reproduce continuously and express desired proteins or features. These cells are generally taken from animal or human tissues. These established cell lines are critical research, drug discovery, and large-scale biomanufacturing tools. Cell isolation, modification, and characterization are all part of the process to assure cell stability and production. Cell lines are critical in the production of biopharmaceuticals, vaccines, and disease research, speeding scientific progress and allowing the efficient creation of novel medicines and bioproducts for a variety of medicinal and industrial uses.
Cell Line Development Market- Market Dynamics
- Growing demand for biopharmaceuticals and personalized medicine propel market demand
As the biopharmaceutical sector grows, so does the need for dependable and efficient cell lines capable of manufacturing complicated biotherapeutics such as monoclonal antibodies and gene treatments. Furthermore, the growth of personalized medicine highlights the need of patient-specific cell lines in developing customized medicines and conducting preclinical testing. This need drives continuing research and development efforts to establish more robust, high-yielding, and adaptable cell lines, accelerating the development and availability of new and targeted therapeutics for a broad variety of illnesses and ailments.
Cell Line Development Market- Key Insights
- As per the analysis shared by our research analyst, the global Cell Line Development market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)
- The Cell Line Development industry is projected to grow at a significant rate due to increasing emphasis on precision medicine in veterinary oncology.
- Based on Product segmentation, Reagent and Media was predicted to show maximum market share in the year 2022
- Based on Type of Cell Lines segmentation, Recombinant cell lines was the leading Product in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Cell Line Development Market- Segmentation Analysis:
The Global Cell Line Development Market is segmented on the basis of Product, Type of Cell Lines, Application, and Region.
The market is divided into four categories based on Product: Reagent and Media, Equipment, Accessories and consumables, Services. The Reagent and Media dominates the market. Cell line development relies on a range of specialized reagents and cell culture media. The demand for these components is driven by the need to provide optimal conditions for cell growth, maintenance, and productivity. These products are essential tools in creating and sustaining high-quality cell lines for research and biomanufacturing applications.
The market is divided into three categories based on Type of Cell Lines: Recombinant cell lines, Hybridomas, Continuous cell lines, Primary cell lines. The Recombinant cell lines sector dominates the market and is likely to maintain its dominance during the forecast period. Recombinant cell lines are in demand for biopharmaceutical production. They are engineered to express specific proteins or biologics efficiently. This demand arises from the need to produce large quantities of biopharmaceuticals, such as monoclonal antibodies and vaccines, to meet healthcare and research needs, making recombinant cell lines crucial in biomanufacturing.
Cell Line Development Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The need for cell line development services and expertise has been gradually expanding in the Asia-Pacific area. This tendency is influenced by a variety of things. For starters, the region\'s booming biotechnology and pharmaceutical industries are increasing the need for dependable cell lines to aid in drug research and development activities. Second, the increasing use of precision medicine and biopharmaceuticals involves the development of customized cell lines matched to Asian genetic profiles. Furthermore, the region\'s expanding markets have witnessed an increase in contract research organizations (CROs) specializing in cell line creation, driving demand even further. As the Asia-Pacific area continues to play an important role in the global healthcare business, there is a strong need for sophisticated cell line development technologies and services.
Cell Line Development Market- Competitive Landscape:
The cell line development competitive environment is characterised by a combination of established and developing enterprises. Companies like as Lonza, Thermo Fisher Scientific, and WuXi Biologics provide a complete range of services and technology. They compete on the basis of technical innovation, size, and competence. Smaller companies, such as Selexis and Solentim, specialise in certain sectors, providing specialised solutions and cutting-edge platforms. The environment is defined by continuous R&D initiatives, cooperation with academic institutions, and the discovery of breakthrough technologies, like as CRISPR-Cas9 technology, that are transforming the sector. As the market for biopharmaceuticals grows, competition pushes breakthroughs in cell line creation.
Recent Developments:
- In May 2023, NewBiologix SA emerged from the shadows as a technological innovation firm producing a patented and ground-breaking platform for the sophisticated creation of cell lines used to produce gene and cell treatments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL LINE DEVELOPMENT MARKET KEY PLAYERS
- Lonza
- Thermo Fisher Scientific
- WuXi Biologics
- Catalent
- Selexis
- Horizon Discovery
- Sartorius
- MilliporeSigma
- Abcam
- ATCC
- Crown Bioscience
- LakePharma
- ProBioGen
- Solentim
- Horizon Therapeutics
GLOBAL CELL LINE DEVELOPMENT MARKET, BY PRODUCT
- Reagent and Media
- Equipment
- Accessories and consumables
- Services
GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE OF CELL LINES
- Recombinant cell lines
- Hybridomas
- Continuous cell lines
- Primary cell lines
GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION
- Bioproduction
- Drug discovery
- Toxicity testing
- Tissue engineering
- Others
GLOBAL CELL LINE DEVELOPMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cell Line Development Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cell Line Development Market Snippet by Product
2.1.2. Cell Line Development Market Snippet by Type of Cell Lines
2.1.3. Cell Line Development Market Snippet by Application
2.1.4. Cell Line Development Market Snippet by Country
2.1.5. Cell Line Development Market Snippet by Region
2.2. Competitive Insights
3. Cell Line Development Key Market Trends
3.1. Cell Line Development Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cell Line Development Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cell Line Development Market Opportunities
3.4. Cell Line Development Market Future Trends
4. Cell Line Development Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cell Line Development Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Cell Line Development Market Landscape
6.1. Cell Line Development Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cell Line Development Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
7.1.2. Reagent and Media
7.1.3. Equipment
7.1.4. Accessories and consumables
7.1.5. Services
8. Cell Line Development Market – By Type of Cell Lines
8.1. Overview
8.1.1. Segment Share Analysis, By Type of Cell Lines, 2022 & 2030 (%)
8.1.2. Recombinant cell lines
8.1.3. Hybridomas
8.1.4. Continuous cell lines
8.1.5. Primary cell lines
9. Cell Line Development Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
9.1.2. Bioproduction
9.1.3. Drug discovery
9.1.4. Toxicity testing
9.1.5. Tissue engineering
9.1.6. Others
10. Cell Line Development Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Cell Line Development Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Cell Line Development Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Cell Line Development Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Cell Line Development Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Cell Line Development Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Cell Line Development Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Lonza
11.2.2. Thermo Fisher Scientific
11.2.3. WuXi Biologics
11.2.4. Catalent
11.2.5. Selexis
11.2.6. Horizon Discovery
11.2.7. Sartorius
11.2.8. MilliporeSigma
11.2.9. Abcam
11.2.10. ATCC
11.2.11. Crown Bioscience
11.2.12. LakePharma
11.2.13. ProBioGen
11.2.14. Solentim
11.2.15. Horizon Therapeutics
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
